|
Name |
1-[3-(3,4,5-Trimethoxyphenyl)propanoyl]-2,3-dihydropyridin-6-one
|
Molecular Formula | C17H21NO5 | |
IUPAC Name* |
1-[3-(3,4,5-trimethoxyphenyl)propanoyl]-2,3-dihydropyridin-6-one
|
|
SMILES |
COC1=CC(=CC(=C1OC)OC)CCC(=O)N2CCC=CC2=O
|
|
InChI |
InChI=1S/C17H21NO5/c1-21-13-10-12(11-14(22-2)17(13)23-3)7-8-16(20)18-9-5-4-6-15(18)19/h4,6,10-11H,5,7-9H2,1-3H3
|
|
InChIKey |
WAGZSQGCUXDBOA-UHFFFAOYSA-N
|
|
Synonyms |
Dihydropiplartine; 8,9-DIHYDROPIPLARTINE; 1-[3-(3,4,5-trimethoxyphenyl)propanoyl]-2,3-dihydropyridin-6-one; 1-(3-(3,4,5-Trimethoxyphenyl)propanoyl)-5,6-dihydropyridin-2(1H)-one; 137760-69-1; CHEMBL2260448; SCHEMBL15422095; ACon1_001503; BRD1177; CHEBI:182635; BRD-1177; NCGC00180438-01; BRD-K26531177-001-01-4; 1-[3-(3,4,5-Trimethoxyphenyl)propanoyl]-5,6-dihydro-2(1H)-pyridinone #; Propan-1-one, 3-(3,4,5-trimethoxyphenyl)-1-(2,3-dihydropyridin-5(1H)-one-1-yl)-
|
|
CAS | NA | |
PubChem CID | 613753 | |
ChEMBL ID | CHEMBL2260448 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 319.4 | ALogp: | 1.9 |
HBD: | 0 | HBA: | 5 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 65.1 | Aromatic Rings: | 2 |
Heavy Atoms: | 23 | QED Weighted: | 0.806 |
Caco-2 Permeability: | -4.573 | MDCK Permeability: | 0.00002270 |
Pgp-inhibitor: | 0.077 | Pgp-substrate: | 0.011 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.18 |
Blood-Brain-Barrier Penetration (BBB): | 0.992 | Plasma Protein Binding (PPB): | 63.55% |
Volume Distribution (VD): | 0.444 | Fu: | 25.26% |
CYP1A2-inhibitor: | 0.326 | CYP1A2-substrate: | 0.858 |
CYP2C19-inhibitor: | 0.486 | CYP2C19-substrate: | 0.849 |
CYP2C9-inhibitor: | 0.34 | CYP2C9-substrate: | 0.774 |
CYP2D6-inhibitor: | 0.06 | CYP2D6-substrate: | 0.457 |
CYP3A4-inhibitor: | 0.565 | CYP3A4-substrate: | 0.503 |
Clearance (CL): | 9.025 | Half-life (T1/2): | 0.823 |
hERG Blockers: | 0.025 | Human Hepatotoxicity (H-HT): | 0.251 |
Drug-inuced Liver Injury (DILI): | 0.046 | AMES Toxicity: | 0.02 |
Rat Oral Acute Toxicity: | 0.005 | Maximum Recommended Daily Dose: | 0.253 |
Skin Sensitization: | 0.86 | Carcinogencity: | 0.125 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.028 |
Respiratory Toxicity: | 0.012 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001423 | 0.662 | D0AO5H | 0.402 | ||||
ENC000340 | 0.458 | D0A8FB | 0.365 | ||||
ENC005523 | 0.455 | D09DHY | 0.346 | ||||
ENC001376 | 0.381 | D02LZB | 0.324 | ||||
ENC005314 | 0.352 | D0D4HN | 0.319 | ||||
ENC005277 | 0.344 | D01FFA | 0.314 | ||||
ENC001403 | 0.342 | D0Y7TS | 0.311 | ||||
ENC000523 | 0.330 | D0S0AF | 0.308 | ||||
ENC005931 | 0.320 | D06GCK | 0.304 | ||||
ENC004456 | 0.319 | D0Q4YI | 0.297 |